Grant: Foundation Grant
McMaster University
$8,310,463.00
Towards a better understanding of Influenza Vaccination: Lessons from the Hutterite Community
FY 2015-16
Summary
The primary goal of my research program is to advance knowledge about the prevention and management of influenza. I will achieve this goal by undertaking analyses using banked specimens and data from randomized trials that I have conducted the Hutterite community, conducting a longitudinal study in this community, and conduct two randomized controlled trials. The primary objectives of my research program are to gain a comprehensive understanding of the impact of the annual administration of influenza vaccine on the prevention of influenza and its complications. The proposed Foundation Grant builds on a research program that I have developed over the past 15 years on the prevention of influenza and other respiratory infections, largely on studies conducted in the Hutterite community.
The specific study aims focus on influenza vaccination. The effect of prior year (s) vaccination on current year vaccine protection is uncertain. The effect of repeated live attenuated influenza vaccination (LAIV) in children is uncertain, where vaccine efficacy (VE) may decline. The impact on herd protection of such repeated vaccination in children is unknown. Although theories have been proposed to explain year to year variability in influenza VE, these have not tested in long-term epidemiologic studies. Identification of clinically useful biomarkers to predict infection, the effect of influenza vaccination on preventing pneumococcal infection in children, the effect of influenza vaccine on reducing myocardial infarction and stroke, and therapy with the anti-viral medication oseltamivir to reduce influenza complications will be assessed. My research program will provide clear results to these questions. Given that > 500 million people receive influenza vaccine annually, this research will have major implications both in Canada and globally.
Department
Program
Foundation Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
333613
Name
Loeb Mark B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Foundation Grant
Projecttitle
Towards a better understanding of Influenza Vaccination: Lessons from the Hutterite Community
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$8,310,463
Cihrequipment2
$0
Programname2
Foundation Grant
Keyworddelim
Clinical Epidemiology; Clinical Trial; Cohort Study; Community Health; Epidemiology; Influenza; Public Health; Randomized Trials; Vaccination
Abstract
The primary goal of my research program is to advance knowledge about the prevention and management of influenza. I will achieve this goal by undertaking analyses using banked specimens and data from randomized trials that I have conducted the Hutterite community, conducting a longitudinal study in this community, and conduct two randomized controlled trials. The primary objectives of my research program are to gain a comprehensive understanding of the impact of the annual administration of influenza vaccine on the prevention of influenza and its complications. The proposed Foundation Grant builds on a research program that I have developed over the past 15 years on the prevention of influenza and other respiratory infections, largely on studies conducted in the Hutterite community.
The specific study aims focus on influenza vaccination. The effect of prior year (s) vaccination on current year vaccine protection is uncertain. The effect of repeated live attenuated influenza vaccination (LAIV) in children is uncertain, where vaccine efficacy (VE) may decline. The impact on herd protection of such repeated vaccination in children is unknown. Although theories have been proposed to explain year to year variability in influenza VE, these have not tested in long-term epidemiologic studies. Identification of clinically useful biomarkers to predict infection, the effect of influenza vaccination on preventing pneumococcal infection in children, the effect of influenza vaccine on reducing myocardial infarction and stroke, and therapy with the anti-viral medication oseltamivir to reduce influenza complications will be assessed. My research program will provide clear results to these questions. Given that > 500 million people receive influenza vaccine annually, this research will have major implications both in Canada and globally.
Competitiondate
201509
Approvedterm2
7 yrs 0 mth
Pinamesdelim
Loeb, Mark B
Approvedterm
7 ans 0 mois
Cihrcontribution2
~ $8,310,463~ $0~